- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04221841
Executive Functions and Reinforcement Sensitivity in Women With Obsessive Compulsive Symptoms
January 11, 2020 updated by: Malahat Amani
University of Bojnord
Methods: The study population consisted of all adult women living in Sabzevar city (Iran).
Using cluster sampling, 365 women were selected as the study sample.
Participants completed Obsessive-Compulsive Inventory, Sensitivity to Punishment and Sensitivity to Reward Questionnaire - Revised and Clarified (SPSRQ-RC) as well as Behavior Rating Inventory of Executive Function (BRIEF).
Data analysis was conducted using correlation and regression tests.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
365
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Khorasan
-
Bojnourd, North Khorasan, Iran, Islamic Republic of, 9453155111
- Malahat Amani
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 52 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
The statistical population consisted of all adult women living in Sabzevar city in 2019.
The sampling was conducted using cluster sampling method.
In randomly selected areas, participants were selected from among local women
Description
Inclusion Criteria:
having age between 18 to 54, be female, be literacy,
Exclusion Criteria:
be male, be illiteracy, having psychotic disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
executive functions
Time Frame: 1 month
|
It was measured by behavior rating inventory of executive function.
it consists of 75 items that are measured on a 5-point Likert scale.
subscales include inhibition, shift, emotional control, self-monitoring, initiation, working memory, planning/organization, task monitoring and organization of materials.
min and max scores are 0 and 150.
respectively.
the higher scores indicate problems in executive functions.
|
1 month
|
obsessive-compulsive symptom
Time Frame: 1 month
|
it was measured by the Obsessive-Compulsive Inventory.
This inventory contains 42 items that are measured on a 5-point Likert scale.
It consists of the sub-scales of washing, controlling, doubting, ordering, obsession, hoarding, and neutralizing.
the higher scores are probably an indicator of obsessive-compulsive disorder.
|
1 month
|
reinforcement sensitivity
Time Frame: 1 month
|
it was measured by Sensitivity to Punishment and Sensitivity to Reward Questionnaire: This 20-item scale measures sensitivity to reward and sensitivity to punishment, which is scored on a 5-point Likert scale (from "totally correct" to "totally incorrect").
the higher scores in subscales of sensitivity to punishment and Sensitivity to Reward indicate high activity in punishment and reward systems.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2019
Primary Completion (Actual)
November 1, 2019
Study Completion (Actual)
December 22, 2019
Study Registration Dates
First Submitted
January 6, 2020
First Submitted That Met QC Criteria
January 6, 2020
First Posted (Actual)
January 9, 2020
Study Record Updates
Last Update Posted (Actual)
January 14, 2020
Last Update Submitted That Met QC Criteria
January 11, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 131820
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Executive Dysfunction
-
Children's Hospital Medical Center, CincinnatiBrady Education FoundationCompleted
-
Florida State UniversityRecruiting
-
University of FribourgSwiss National Science Foundation; University of Bern; University of Geneva,...CompletedExecutive Dysfunction | LanguageSwitzerland
-
University GhentUniversity Hospital, GhentCompletedChild | Motor Activity | Executive Dysfunction
-
VA Office of Research and DevelopmentRecruitingExecutive Dysfunction | Poor Exercise AdherenceUnited States
-
Lawson Health Research InstituteTerminatedExecutive Dysfunction | Repetitive Transcranial Magnetic Stimulation | Gait PerformanceCanada
-
Children's National Research InstituteAppleTree Institute; The Maddux SchoolEnrolling by invitationExecutive DysfunctionUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Unknown
-
Wayne State UniversityWithdrawnPain | Executive Dysfunction | MoodUnited States
-
University Hospital of North NorwayUiT The Arctic University of NorwayRecruitingDepression | Executive DysfunctionNorway
Clinical Trials on descriptive
-
Tokat Gaziosmanpasa UniversityCompletedHospitalism | Children, Only | COVID-19 Pandemic | Nurse's Role | FeelingsTurkey
-
Hacettepe UniversityCompleted
-
Samsun UniversityCompletedLong-term Consequences of COVID-19 InfectionTurkey
-
Centre Hospitalier Universitaire de BesanconCompletedPalliative Care | Platelet TransfusionFrance
-
University Hospital, ToulouseTerminatedCarpal Tunnel Syndrome | Transthyretin AmyloidosisFrance
-
Malahat AmaniCompletedRisk-Taking | Self-Control | Humor as TopicIran, Islamic Republic of
-
Universidad de GranadaCompleted
-
University of California, MercedCompleted
-
Lene KrenkLundbeck FoundationCompletedPostoperative Cognitive Dysfunction After Total Knee or Hip Replacement Surgery in Fast-track Set-upPostoperative Cognitive DysfunctionDenmark
-
Bozok UniversityCompletedMultiple Sclerosis | Sexual Dysfunction | QuestionnairesTurkey